Teladoc Inc (TDOC) was Initiated by Craig Hallum to “Buy”. Craig Hallum advised their investors in a research report released on Nov 28, 2016.
Many Wall Street Analysts have commented on Teladoc Inc. Chardan Capital Markets Initiated Teladoc Inc on Nov 16, 2016 to “Buy”, Price Target of the shares are set at $24.
On the company’s financial health, Teladoc Inc reported $-0.33 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Oct 27, 2016. Analyst had a consensus of $-0.35. The company had revenue of $32.40 million for the quarter, compared to analysts expectations of $32.28 million. The company’s revenue was up 62.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.35 EPS.
Teladoc Inc closed down -0.15 points or -0.82% at $18.15 with 1,01,479 shares getting traded on Friday. Post opening the session at $18.45, the shares hit an intraday low of $18 and an intraday high of $18.45 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
In a different news, on Nov 17, 2016, Mark Hirschhorn (Executive VP, COO and CFO) sold 10,000 shares at $17.18 per share price. According to the SEC, on Sep 2, 2016, Michael H. King (Chief Sales Officer) sold 15,000 shares at $17.56 per share price. On Aug 18, 2016, Jason N Gorevic (President & CEO) sold 40,000 shares at $17.92 per share price, according to the Form-4 filing with the securities and exchange commission.
Teladoc Inc. is a telehealth company. The Company offers an on-demand healthcare platform through mobile devices Internet video and phone. Its solution connects consumers with physicians and behavioral health professionals or its providers who treat various conditions and cases from acute diagnoses such as upper respiratory infection urinary tract infection and sinusitis to dermatological conditions anxiety and smoking cessation. The Teladoc solution enables accessing on-demand healthcare for employers health plans and health systems. Its platform provides accessing physicians clinical programs and consumer engagement strategies. Its platform provides for interconnectivity between healthcare constituents. It offers solutions such as remote patient monitoring post-discharge treatment plan adherence and in-home and chronic care. Its customers also include channel partners such as brokers resellers and consultants who sell into a range of small medium and large enterprises.